POMNasdaqRetail-Miscellaneous RetailFiscal year ends December 31

POMDOCTOR Ltd

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on May 14, 2026

$0.53−0.10 (-15.88%)

Close on Oct 19, 2026

POMDOCTOR Ltd income statement

AnnualQuarterlyTTM

Millions of CNY, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31
Revenue	400	343	305
Cost of Revenue	348	295	266
Gross Profit	52	48	39
Research & Development	13	3.00	3.37
Selling, General & Admin	156	68	56
Selling & Marketing	96	56	44
General & Administrative	60	12	12
Operating Expenses	171	73	61
Operating Income	-119	-26	-22
Interest Expense	3.94	3.63	1.92
Other Non-Operating Income	-12	-12	-15
Gain (Loss) on Sale of Assets	–	0.00	–
Pretax Income	-131	-37	-37
Income Tax Expense	0.00	–	–
Income from Continuing Operations	-131	-37	-37
Net Income incl. Noncontrolling Interests	-131	-37	-37
Minority Interest in Earnings	0.00	0.03	0.00
Net Income to Common	-213	-143	-145
EPS (Basic)(per share)	-21.96	-22.72	-23.04
EPS (Diluted)(per share)	-21.96	-22.72	-23.04
Shares Outstanding (Basic, Weighted)(shares)	9.68	6.31	6.31
Shares Outstanding (Diluted, Weighted)(shares)	9.68	6.31	6.31

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY2025

Gross margin: 13.1%
Operating margin: -29.7%
Net margin: –
Return on equity, FY2025: –

Financial strength

Current ratio: 0.35
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 6.0%

Valuation

P/E ratio: –
Price to sales: –
Price to book: –
Dividend yield: –

Valuation ratios need the share price and fill in once daily prices are connected.